{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T18:31:35Z","timestamp":1786991495611,"version":"build-2736575974"},"reference-count":137,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,14]],"date-time":"2023-09-14T00:00:00Z","timestamp":1694649600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004731","name":"Natural Science Foundation of Zhejiang Province","doi-asserted-by":"publisher","award":["LBY23H080001"],"award-info":[{"award-number":["LBY23H080001"]}],"id":[{"id":"10.13039\/501100004731","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004731","name":"Natural Science Foundation of Zhejiang Province","doi-asserted-by":"publisher","award":["LBY23H080004"],"award-info":[{"award-number":["LBY23H080004"]}],"id":[{"id":"10.13039\/501100004731","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004731","name":"Natural Science Foundation of Zhejiang Province","doi-asserted-by":"publisher","award":["LBY23H080005"],"award-info":[{"award-number":["LBY23H080005"]}],"id":[{"id":"10.13039\/501100004731","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017594","name":"Medical Science and Technology Project of Zhejiang Province","doi-asserted-by":"publisher","award":["2022KY503"],"award-info":[{"award-number":["2022KY503"]}],"id":[{"id":"10.13039\/501100017594","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017594","name":"Medical Science and Technology Project of Zhejiang Province","doi-asserted-by":"publisher","award":["2023RC228"],"award-info":[{"award-number":["2023RC228"]}],"id":[{"id":"10.13039\/501100017594","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017594","name":"Medical Science and Technology Project of Zhejiang Province","doi-asserted-by":"publisher","award":["2023RC004"],"award-info":[{"award-number":["2023RC004"]}],"id":[{"id":"10.13039\/501100017594","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017594","name":"Medical Science and Technology Project of Zhejiang Province","doi-asserted-by":"publisher","award":["2023KY550"],"award-info":[{"award-number":["2023KY550"]}],"id":[{"id":"10.13039\/501100017594","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82102938"],"award-info":[{"award-number":["82102938"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82202429"],"award-info":[{"award-number":["82202429"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/j.biopha.2023.115522","type":"journal-article","created":{"date-parts":[[2023,9,25]],"date-time":"2023-09-25T05:04:28Z","timestamp":1695618268000},"page":"115522","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"special_numbering":"C","title":["The potential of targeting cuproptosis in the treatment of kidney renal clear cell carcinoma"],"prefix":"10.1016","volume":"167","author":[{"given":"Guojie","family":"Lei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lusheng","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanhua","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenxia","family":"Bian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingyan","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junyu","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanchun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7519-8531","authenticated-orcid":false,"given":"Jing","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.biopha.2023.115522_bib1","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.3390\/nu2111106","article-title":"Polyphenols and human health: prevention of disease and mechanisms of action","volume":"2","author":"Vauzour","year":"2010","journal-title":"Nutrients"},{"issue":"9","key":"10.1016\/j.biopha.2023.115522_bib2","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1038\/s41585-019-0211-5","article-title":"The Cancer Genome Atlas of renal cell carcinoma: findings and clinical implications","volume":"16","author":"Linehan","year":"2019","journal-title":"Nat. Rev. Urol."},{"issue":"3","key":"10.1016\/j.biopha.2023.115522_bib3","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.eururo.2014.10.002","article-title":"International variations and trends in renal cell carcinoma incidence and mortality","volume":"67","author":"Znaor","year":"2015","journal-title":"Eur. Urol."},{"key":"10.1016\/j.biopha.2023.115522_bib4","doi-asserted-by":"crossref","first-page":"g4797","DOI":"10.1136\/bmj.g4797","article-title":"Renal cell carcinoma","volume":"349","author":"Jonasch","year":"2014","journal-title":"BMJ"},{"key":"10.1016\/j.biopha.2023.115522_bib5","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.bbrc.2022.09.022","article-title":"Programmed cell death: Past, present and future","volume":"633","author":"Kopeina","year":"2022","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"4","key":"10.1016\/j.biopha.2023.115522_bib6","doi-asserted-by":"crossref","first-page":"11187","DOI":"10.1080\/21655979.2022.2062537","article-title":"Functional deficiency of succinate dehydrogenase promotes tumorigenesis and development of clear cell renal cell carcinoma through weakening of ferroptosis","volume":"13","author":"Yang","year":"2022","journal-title":"Bioengineered"},{"issue":"1","key":"10.1016\/j.biopha.2023.115522_bib7","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1038\/s41467-019-09277-9","article-title":"A GPX4-dependent cancer cell state underlies the clear-cell morphology and confers sensitivity to ferroptosis","volume":"10","author":"Zou","year":"2019","journal-title":"Nat. Commun."},{"issue":"15","key":"10.1016\/j.biopha.2023.115522_bib8","doi-asserted-by":"crossref","first-page":"5943","DOI":"10.7150\/ijbs.77774","article-title":"FTO-mediated autophagy promotes progression of clear cell renal cell carcinoma via regulating SIK2 mRNA stability","volume":"18","author":"Xu","year":"2022","journal-title":"Int. J. Biol. Sci."},{"issue":"11","key":"10.1016\/j.biopha.2023.115522_bib9","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1038\/s41580-020-0270-8","article-title":"Emerging connectivity of programmed cell death pathways and its physiological implications","volume":"21","author":"Bedoui","year":"2020","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"9","key":"10.1016\/j.biopha.2023.115522_bib10","doi-asserted-by":"crossref","first-page":"R421","DOI":"10.1016\/j.cub.2021.03.054","article-title":"Copper biology","volume":"31","author":"Tsang","year":"2021","journal-title":"Curr. Biol."},{"issue":"6586","key":"10.1016\/j.biopha.2023.115522_bib11","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1126\/science.abf0529","article-title":"Copper induces cell death by targeting lipoylated TCA cycle proteins","volume":"375","author":"Tsvetkov","year":"2022","journal-title":"Science"},{"key":"10.1016\/j.biopha.2023.115522_bib12","first-page":"1","article-title":"Copper-dependent autophagic degradation of GPX4 drives ferroptosis","author":"Xue","year":"2023","journal-title":"Autophagy"},{"issue":"5","key":"10.1016\/j.biopha.2023.115522_bib13","first-page":"5791","article-title":"Prognostic value of copper transporter 1 expression in patients with clear cell renal cell carcinoma","volume":"14","author":"Xia","year":"2017","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.biopha.2023.115522_bib14","article-title":"Cuproptosis and cuproptosis-related genes in rheumatoid arthritis: Implication, prospects, and perspectives","volume":"13","author":"Zhao","year":"2022","journal-title":"Front Immunol."},{"issue":"9","key":"10.1016\/j.biopha.2023.115522_bib15","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.1002\/iub.2341","article-title":"Copper homeostasis: emerging target for cancer treatment","volume":"72","author":"Li","year":"2020","journal-title":"IUBMB Life"},{"issue":"11","key":"10.1016\/j.biopha.2023.115522_bib16","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1007\/s00204-014-1355-y","article-title":"Copper: toxicological relevance and mechanisms","volume":"88","author":"Gaetke","year":"2014","journal-title":"Arch. Toxicol."},{"issue":"3","key":"10.1016\/j.biopha.2023.115522_bib17","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1038\/nchembio.72","article-title":"Mechanisms for copper acquisition, distribution and regulation","volume":"4","author":"Kim","year":"2008","journal-title":"Nat. Chem. Biol."},{"issue":"4","key":"10.1016\/j.biopha.2023.115522_bib18","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1002\/med.20174","article-title":"Copper in diseases and treatments, and copper-based anticancer strategies","volume":"30","author":"Tisato","year":"2010","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.biopha.2023.115522_bib19","article-title":"Copper radical oxidases: galactose oxidase, glyoxal oxidase, and beyond!","author":"Fong","year":"2022","journal-title":"Essays Biochem."},{"issue":"2","key":"10.1016\/j.biopha.2023.115522_bib20","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.cbpa.2010.01.003","article-title":"Human copper homeostasis: a network of interconnected pathways","volume":"14","author":"Lutsenko","year":"2010","journal-title":"Curr. Opin. Chem. Biol."},{"issue":"5 Suppl","key":"10.1016\/j.biopha.2023.115522_bib21","doi-asserted-by":"crossref","first-page":"960s","DOI":"10.1093\/ajcn\/67.5.960S","article-title":"Human whole-body copper metabolism","volume":"67","author":"Turnlund","year":"1998","journal-title":"Am. J. Clin. Nutr."},{"issue":"4","key":"10.1016\/j.biopha.2023.115522_bib22","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1002\/iub.1618","article-title":"Copper metallothioneins","volume":"69","author":"Calvo","year":"2017","journal-title":"IUBMB Life"},{"issue":"16","key":"10.1016\/j.biopha.2023.115522_bib23","first-page":"14","article-title":"STEAP1-4 (six-transmembrane epithelial antigen of the prostate 1-4) and their clinical implications for prostate cancer","author":"Xu","year":"2022","journal-title":"Cancers"},{"issue":"6","key":"10.1016\/j.biopha.2023.115522_bib24","first-page":"9","article-title":"Copper Sources for Sod1 Activation","author":"Boyd","year":"2020","journal-title":"Antioxidants"},{"key":"10.1016\/j.biopha.2023.115522_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2020.110401","article-title":"The contribution of copper efflux transporters ATP7A and ATP7B to chemoresistance and personalized medicine in ovarian cancer","volume":"129","author":"Lukanovic","year":"2020","journal-title":"Biomed. Pharm."},{"issue":"44","key":"10.1016\/j.biopha.2023.115522_bib26","doi-asserted-by":"crossref","first-page":"18169","DOI":"10.1074\/jbc.M117.811752","article-title":"The metal chaperone Atox1 regulates the activity of the human copper transporter ATP7B by modulating domain dynamics","volume":"292","author":"Yu","year":"2017","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.biopha.2023.115522_bib27","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/nrneurol.2010.180","article-title":"ATP7A-related copper transport diseases-emerging concepts and future trends","volume":"7","author":"Kaler","year":"2011","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.biopha.2023.115522_bib28","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3390\/antiox5030025","article-title":"The role of copper chaperone Atox1 in coupling redox homeostasis to intracellular copper distribution","volume":"5","author":"Hatori","year":"2016","journal-title":"Antioxidants"},{"issue":"4","key":"10.1016\/j.biopha.2023.115522_bib29","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines9040391","article-title":"ATP7A-regulated enzyme metalation and trafficking in the menkes disease puzzle","volume":"9","author":"Horn","year":"2021","journal-title":"Biomedicines"},{"key":"10.1016\/j.biopha.2023.115522_bib30","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.ceb.2019.02.009","article-title":"Trafficking mechanisms of P-type ATPase copper transporters","volume":"59","author":"Hartwig","year":"2019","journal-title":"Curr. Opin. Cell Biol."},{"issue":"3","key":"10.1016\/j.biopha.2023.115522_bib31","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/s00418-013-1123-8","article-title":"Golgi in copper homeostasis: a view from the membrane trafficking field","volume":"140","author":"Polishchuk","year":"2013","journal-title":"Histochem Cell Biol."},{"issue":"25","key":"10.1016\/j.biopha.2023.115522_bib32","doi-asserted-by":"crossref","first-page":"12167","DOI":"10.1073\/pnas.1900172116","article-title":"Ratiometric two-photon microscopy reveals attomolar copper buffering in normal and Menkes mutant cells","volume":"116","author":"Morgan","year":"2019","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"6491","key":"10.1016\/j.biopha.2023.115522_bib33","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1126\/science.aaz8899","article-title":"Elesclomol alleviates Menkes pathology and mortality by escorting Cu to cuproenzymes in mice","volume":"368","author":"Guthrie","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.biopha.2023.115522_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2021.102122","article-title":"Overcoming the compensatory elevation of NRF2 renders hepatocellular carcinoma cells more vulnerable to disulfiram\/copper-induced ferroptosis","volume":"46","author":"Ren","year":"2021","journal-title":"Redox Biol."},{"issue":"7","key":"10.1016\/j.biopha.2023.115522_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2022.102139","article-title":"Elesclomol elevates cellular and mitochondrial iron levels by delivering copper to the iron import machinery","volume":"298","author":"Garza","year":"2022","journal-title":"J. Biol. Chem."},{"issue":"12","key":"10.1016\/j.biopha.2023.115522_bib36","article-title":"Photothermally triggered copper payload release for cuproptosis-promoted","volume":"62","author":"Zhou","year":"2023","journal-title":"Cancer Synerg. Ther. Angew. Chem. (Int. Ed. Engl. )"},{"issue":"43","key":"10.1016\/j.biopha.2023.115522_bib37","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202204733","article-title":"An enzyme-engineered nonporous copper(I) coordination polymer nanoplatform for cuproptosis-based synergistic cancer therapy","volume":"34","author":"Xu","year":"2022","journal-title":"Adv. Mater."},{"issue":"11","key":"10.1016\/j.biopha.2023.115522_bib38","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1039\/C7MT00221A","article-title":"The mitochondrion: a central architect of copper homeostasis","volume":"9","author":"Baker","year":"2017","journal-title":"Metallomics"},{"issue":"1","key":"10.1016\/j.biopha.2023.115522_bib39","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.bbamcr.2008.05.002","article-title":"\"Pulling the plug\" on cellular copper: the role of mitochondria in copper export","volume":"1793","author":"Leary","year":"2009","journal-title":"Biochim Biophys. Acta"},{"issue":"1","key":"10.1016\/j.biopha.2023.115522_bib40","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.bbadis.2009.07.013","article-title":"Cytochrome c oxidase deficiency: patients and animal models","volume":"1802","author":"Diaz","year":"2010","journal-title":"Biochim Biophys. Acta"},{"key":"10.1016\/j.biopha.2023.115522_bib41","doi-asserted-by":"crossref","first-page":"2430","DOI":"10.1038\/ncomms3430","article-title":"Human copper chaperone for superoxide dismutase 1 mediates its own oxidation-dependent import into mitochondria","volume":"4","author":"Suzuki","year":"2013","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.biopha.2023.115522_bib42","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.drudis.2015.10.001","article-title":"Expanding roles of superoxide dismutases in cell regulation and cancer","volume":"21","author":"Che","year":"2016","journal-title":"Drug Discov. Today"},{"issue":"3","key":"10.1016\/j.biopha.2023.115522_bib43","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1038\/sj.onc.1208207","article-title":"CuZnSOD deficiency leads to persistent and widespread oxidative damage and hepatocarcinogenesis later in life","volume":"24","author":"Elchuri","year":"2005","journal-title":"Oncogene"},{"issue":"14","key":"10.1016\/j.biopha.2023.115522_bib44","doi-asserted-by":"crossref","first-page":"14447","DOI":"10.1074\/jbc.M312693200","article-title":"Yeast contain a non-proteinaceous pool of copper in the mitochondrial matrix","volume":"279","author":"Cobine","year":"2004","journal-title":"J. Biol. Chem."},{"issue":"5","key":"10.1016\/j.biopha.2023.115522_bib45","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1016\/j.jmb.2011.09.010","article-title":"Functional characterization of Fdx1: evidence for an evolutionary relationship between P450-type and ISC-type ferredoxins","volume":"413","author":"Ewen","year":"2011","journal-title":"J. Mol. Biol."},{"issue":"3","key":"10.1016\/j.biopha.2023.115522_bib46","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1021\/acs.biochem.6b00447","article-title":"Human mitochondrial ferredoxin 1 (FDX1) and ferredoxin 2 (FDX2) both bind cysteine desulfurase and donate electrons for iron-sulfur cluster biosynthesis","volume":"56","author":"Cai","year":"2017","journal-title":"Biochemistry"},{"issue":"2","key":"10.1016\/j.biopha.2023.115522_bib47","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1021\/jacs.6b09567","article-title":"[4Fe-4S] cluster assembly in mitochondria and its impairment by copper","volume":"139","author":"Brancaccio","year":"2017","journal-title":"J. Am. Chem. Soc."},{"issue":"10","key":"10.1016\/j.biopha.2023.115522_bib48","doi-asserted-by":"crossref","first-page":"2512","DOI":"10.1128\/JB.00058-10","article-title":"Copper stress affects iron homeostasis by destabilizing iron-sulfur cluster formation in Bacillus subtilis","volume":"192","author":"Chillappagari","year":"2010","journal-title":"J. Bacteriol."},{"key":"10.1016\/j.biopha.2023.115522_bib49","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.biomaterials.2017.09.008","article-title":"Cuprous oxide nanoparticles trigger ER stress-induced apoptosis by regulating copper trafficking and overcoming resistance to sunitinib therapy in renal cancer","volume":"146","author":"Yang","year":"2017","journal-title":"Biomaterials"},{"issue":"1","key":"10.1016\/j.biopha.2023.115522_bib50","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1038\/s41598-018-19873-2","article-title":"Copper(I)-binding properties of de-coppering drugs for the treatment of Wilson disease. alpha-Lipoic acid as a potential anti-copper agent","volume":"8","author":"Smirnova","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biopha.2023.115522_bib51","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1172\/jci.insight.84897","article-title":"Mitochondrial protein hyperacetylation in the failing heart","volume":"1","author":"Horton","year":"2016","journal-title":"JCI Insight"},{"issue":"12","key":"10.1016\/j.biopha.2023.115522_bib52","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1161\/CIRCULATIONAHA.116.022495","article-title":"Normalization of NAD+ redox balance as a therapy for heart failure","volume":"134","author":"Lee","year":"2016","journal-title":"Circulation"},{"issue":"20","key":"10.1016\/j.biopha.2023.115522_bib53","doi-asserted-by":"crossref","first-page":"7522","DOI":"10.1074\/jbc.TM117.000259","article-title":"Lipoic acid metabolism and mitochondrial redox regulation","volume":"293","author":"Solmonson","year":"2018","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.biopha.2023.115522_bib54","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.cbpa.2017.11.003","article-title":"Protein lipoylation: an evolutionarily conserved metabolic regulator of health and disease","volume":"42","author":"Rowland","year":"2018","journal-title":"Curr. Opin. Chem. Biol."},{"issue":"12","key":"10.1016\/j.biopha.2023.115522_bib55","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1016\/j.freeradbiomed.2007.02.033","article-title":"Targeting lipoic acid to mitochondria: synthesis and characterization of a triphenylphosphonium-conjugated alpha-lipoyl derivative","volume":"42","author":"Brown","year":"2007","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.biopha.2023.115522_bib56","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.freeradbiomed.2023.05.017","article-title":"Copper exerts cytotoxicity through inhibition of iron-sulfur cluster biogenesis on ISCA1\/ISCA2\/ISCU assembly proteins","volume":"204","author":"Du","year":"2023","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.biopha.2023.115522_bib57","article-title":"4-Octyl itaconate inhibits aerobic glycolysis by targeting GAPDH to promote cuproptosis in colorectal cancer","volume":"159","author":"Yang","year":"2023","journal-title":"Biomed. Pharmacother. Biomed. Pharmacother."},{"key":"10.1016\/j.biopha.2023.115522_bib58","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1186\/s12935-019-0939-2","article-title":"Cell death-related molecules and biomarkers for renal cell carcinoma targeted therapy","volume":"19","author":"Lai","year":"2019","journal-title":"Cancer Cell Int."},{"issue":"1","key":"10.1016\/j.biopha.2023.115522_bib59","doi-asserted-by":"crossref","first-page":"499","DOI":"10.7314\/APJCP.2013.14.1.499","article-title":"Levels of serum trace elements in renal cell carcinoma cases","volume":"14","author":"Pirincci","year":"2013","journal-title":"Asian Pac. J. Cancer Prev."},{"issue":"1","key":"10.1016\/j.biopha.2023.115522_bib60","first-page":"45","article-title":"Levels of cadmium, zinc and copper in renal cell carcinoma and normal kidney","volume":"3","author":"Hardell","year":"1994","journal-title":"Eur. J. Cancer Prev. Off. J. Eur. Cancer Prev. Organ. (ECP)"},{"issue":"3","key":"10.1016\/j.biopha.2023.115522_bib61","doi-asserted-by":"crossref","DOI":"10.1016\/j.urolonc.2021.11.017","article-title":"Association of heavy metals and trace elements in renal cell carcinoma: a case-controlled study","volume":"40","author":"Panaiyadiyan","year":"2022","journal-title":"Urol. Oncol."},{"issue":"24","key":"10.1016\/j.biopha.2023.115522_bib62","doi-asserted-by":"crossref","first-page":"30460","DOI":"10.1007\/s11356-020-09402-y","article-title":"Quantitative and qualitative evaluation of toxic metals and trace elements in the tissues of renal cell carcinoma compared with the adjacent non-cancerous and control kidney tissues","volume":"27","author":"Abdel-Gawad","year":"2020","journal-title":"Environ. Sci. Pollut. Res Int"},{"issue":"1","key":"10.1016\/j.biopha.2023.115522_bib63","doi-asserted-by":"crossref","DOI":"10.1016\/j.urolonc.2015.08.013","article-title":"Decreased expression of CTR2 predicts poor prognosis of patients with clear cell renal cell carcinoma","volume":"34","author":"Xia","year":"2016","journal-title":"Urol. Oncol."},{"issue":"8","key":"10.1016\/j.biopha.2023.115522_bib64","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1158\/2159-8290.CD-18-1354","article-title":"The metabolic basis of kidney cancer","volume":"9","author":"Linehan","year":"2019","journal-title":"Cancer Discov."},{"issue":"9374","key":"10.1016\/j.biopha.2023.115522_bib65","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1016\/S0140-6736(03)13643-4","article-title":"von Hippel-Lindau disease","volume":"361","author":"Lonser","year":"2003","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.biopha.2023.115522_bib66","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1038\/ejhg.2010.175","article-title":"A clinical and scientific review","volume":"19","author":"Maher","year":"2011","journal-title":"Eur. J. Hum. Genet."},{"key":"10.1016\/j.biopha.2023.115522_bib67","doi-asserted-by":"crossref","unstructured":"Comprehensive molecular characterization of clear cell renal cell carcinoma. Nature 2013, 499(7456): 43\u201349.","DOI":"10.1038\/nature12222"},{"issue":"8","key":"10.1016\/j.biopha.2023.115522_bib68","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1038\/ng.2699","article-title":"Integrated molecular analysis of clear-cell renal cell carcinoma","volume":"45","author":"Sato","year":"2013","journal-title":"Nat. Genet."},{"key":"10.1016\/j.biopha.2023.115522_bib69","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.mce.2014.10.017","article-title":"Regulation of cytokine-inducible SH2-containing protein (CIS) by ubiquitination and Elongin B\/C interaction","volume":"401","author":"Jensik","year":"2015","journal-title":"Mol. Cell. Endocrinol."},{"issue":"1","key":"10.1016\/j.biopha.2023.115522_bib70","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1042\/BJ20060354","article-title":"The von Hippel\u2013Lindau tumour-suppressor protein interaction with protein kinase C\u03b4","volume":"397","author":"Iturrioz","year":"2006","journal-title":"Biochem. J."},{"issue":"9","key":"10.1016\/j.biopha.2023.115522_bib71","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/nrc885","article-title":"Molecular basis of the VHL hereditary cancer syndrome","volume":"2","author":"Kaelin","year":"2002","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.biopha.2023.115522_bib72","first-page":"11","article-title":"The VHL\/HIF axis in the development and treatment of pheochromocytoma\/paraganglioma","author":"Peng","year":"2020","journal-title":"Front. Endocrinol."},{"issue":"5516","key":"10.1016\/j.biopha.2023.115522_bib73","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1126\/science.1059796","article-title":"Targeting of HIF-alpha to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation","volume":"292","author":"Jaakkola","year":"2001","journal-title":"Science"},{"issue":"8","key":"10.1016\/j.biopha.2023.115522_bib74","first-page":"4074","article-title":"Pan-cancer profiles of the cuproptosis gene set","volume":"12","author":"Liu","year":"2022","journal-title":"Am. J. Cancer Res."},{"issue":"4","key":"10.1016\/j.biopha.2023.115522_bib75","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1016\/j.eururo.2015.09.014","article-title":"Metabolic modulation of clear-cell renal cell carcinoma with dichloroacetate, an inhibitor of pyruvate dehydrogenase kinase","volume":"69","author":"Kinnaird","year":"2016","journal-title":"Eur. Urol."},{"issue":"4","key":"10.1016\/j.biopha.2023.115522_bib76","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1038\/s41581-020-00359-2","article-title":"Clear cell renal cell carcinoma ontogeny and mechanisms of lethality","volume":"17","author":"Jonasch","year":"2021","journal-title":"Nat. Rev. Nephrol."},{"issue":"6","key":"10.1016\/j.biopha.2023.115522_bib77","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1038\/s42255-022-00593-x","article-title":"Impaired oxygen-sensitive regulation of mitochondrial biogenesis within the von Hippel-Lindau syndrome","volume":"4","author":"Li","year":"2022","journal-title":"Nat. Metab."},{"issue":"43","key":"10.1016\/j.biopha.2023.115522_bib78","doi-asserted-by":"crossref","first-page":"18410","DOI":"10.1073\/pnas.1008924107","article-title":"Mitochondrial Lon protease regulates mitochondrial DNA copy number and transcription by selective degradation of mitochondrial transcription factor A (TFAM)","volume":"107","author":"Matsushima","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"10","key":"10.1016\/j.biopha.2023.115522_bib79","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1039\/C4MT00052H","article-title":"Copper-dependent and -independent hypoxia-inducible factor-1 regulation of gene expression","volume":"6","author":"Zhang","year":"2014","journal-title":"Met. Integr. Biometal Sci."},{"issue":"1","key":"10.1016\/j.biopha.2023.115522_bib80","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1124\/mol.108.051516","article-title":"Copper regulation of hypoxia-inducible factor-1 activity","volume":"75","author":"Feng","year":"2009","journal-title":"Mol. Pharmacol."},{"issue":"10","key":"10.1016\/j.biopha.2023.115522_bib81","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadis.2020.165842","article-title":"Activation of HIF-1 signaling ameliorates liver steatosis in zebrafish atp7b deficiency (Wilson's disease) models","volume":"1866","author":"Mi","year":"2020","journal-title":"Biochim. Et. Biophys. Acta Mol. Basis Dis."},{"issue":"2","key":"10.1016\/j.biopha.2023.115522_bib82","first-page":"429","article-title":"Copper affects the binding of HIF-1\u03b1 to the critical motifs of its target genes","volume":"11","author":"Wu","year":"2019","journal-title":"Met.: Integr. biometal Sci."},{"issue":"7","key":"10.1016\/j.biopha.2023.115522_bib83","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbamcr.2021.119022","article-title":"The Vhl E3 ubiquitin ligase complex regulates melanisation via sima, cnc and the copper import protein Ctr1A","volume":"1868","author":"Zhang","year":"2021","journal-title":"Biochim. Et. Biophys. Acta Mol. Cell Res."},{"key":"10.1016\/j.biopha.2023.115522_bib84","doi-asserted-by":"crossref","first-page":"8297011","DOI":"10.1155\/2022\/8297011","article-title":"The prognostic value and immunological role of STEAP1 in pan-cancer: a result of data-based analysis","volume":"2022","author":"Zhao","year":"2022","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.biopha.2023.115522_bib85","article-title":"Pan-cancer genetic analysis of cuproptosis and copper metabolism-related gene set","volume":"12","author":"Liu","year":"2022","journal-title":"Front Oncol."},{"key":"10.1016\/j.biopha.2023.115522_bib86","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1146\/annurev-biochem-013118-111540","article-title":"Mechanisms of mitochondrial iron-sulfur protein biogenesis","volume":"89","author":"Lill","year":"2020","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.biopha.2023.115522_bib87","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.952129","article-title":"Comprehensive analysis of the potential cuproptosis-related biomarker LIAS that regulates prognosis and immunotherapy of pan-cancers","volume":"12","author":"Cai","year":"2022","journal-title":"Front. Oncol."},{"issue":"4","key":"10.1016\/j.biopha.2023.115522_bib88","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.21873\/anticanres.16299","article-title":"The prognostic role of ACO2 in renal cell carcinoma","volume":"43","author":"Jaworski","year":"2023","journal-title":"Anticancer Res."},{"key":"10.1016\/j.biopha.2023.115522_bib89","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.639408","article-title":"SDHB suppresses the tumorigenesis and development of ccRCC by inhibiting glycolysis","volume":"11","author":"Fang","year":"2021","journal-title":"Front. Oncol."},{"issue":"7","key":"10.1016\/j.biopha.2023.115522_bib90","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24076849","article-title":"POLD1 as a prognostic biomarker correlated with cell proliferation and immune infiltration in clear cell renal cell carcinoma","volume":"24","author":"Tian","year":"2023","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.biopha.2023.115522_bib91","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.981764","article-title":"Multi-omics pan-cancer study of cuproptosis core gene FDX1 and its role in kidney renal clear cell carcinoma","volume":"13","author":"Xu","year":"2022","journal-title":"Front. Immunol."},{"issue":"30","key":"10.1016\/j.biopha.2023.115522_bib92","doi-asserted-by":"crossref","first-page":"E7063","DOI":"10.1073\/pnas.1805862115","article-title":"Protein moonlighting elucidates the essential human pathway catalyzing lipoic acid assembly on its cognate enzymes","volume":"115","author":"Cao","year":"2018","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"4","key":"10.1016\/j.biopha.2023.115522_bib93","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1002\/cac2.12413","article-title":"N6-methyladenosine-modified DBT alleviates lipid accumulation and inhibits tumor progression in clear cell renal cell carcinoma through the ANXA2\/YAP axis-regulated Hippo pathway","volume":"43","author":"Miao","year":"2023","journal-title":"Cancer Commun."},{"issue":"39","key":"10.1016\/j.biopha.2023.115522_bib94","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2106947118","article-title":"Functional succinate dehydrogenase deficiency is a common adverse feature of clear cell renal cancer","volume":"118","author":"Aggarwal","year":"2021","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.biopha.2023.115522_bib95","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.ctrv.2018.07.009","article-title":"Current and emerging therapies for first-line treatment of metastatic clear cell renal cell carcinoma","volume":"70","author":"Atkins","year":"2018","journal-title":"Cancer Treat. Rev."},{"issue":"10 Suppl","key":"10.1016\/j.biopha.2023.115522_bib96","doi-asserted-by":"crossref","first-page":"2282","DOI":"10.1002\/cncr.24238","article-title":"Complexity of tumor vasculature in clear cell renal cell carcinoma","volume":"115","author":"Qian","year":"2009","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.biopha.2023.115522_bib97","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.semcancer.2012.06.001","article-title":"The VHL\/HIF axis in clear cell renal carcinoma","volume":"23","author":"Shen","year":"2013","journal-title":"Semin. Cancer Biol."},{"issue":"2","key":"10.1016\/j.biopha.2023.115522_bib98","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1056\/NEJMoa065044","article-title":"Sunitinib versus interferon alfa in metastatic renal-cell carcinoma","volume":"356","author":"Motzer","year":"2007","journal-title":"N. Engl. J. Med."},{"issue":"6","key":"10.1016\/j.biopha.2023.115522_bib99","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1200\/JCO.2009.23.9764","article-title":"Pazopanib in locally advanced or metastatic renal cell carcinoma: results of a randomized phase III trial","volume":"28","author":"Sternberg","year":"2010","journal-title":"J. Clin. Oncol.: Off. J. Am. Soc. Clin. Oncol."},{"issue":"19","key":"10.1016\/j.biopha.2023.115522_bib100","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1056\/NEJMoa1510665","article-title":"Nivolumab versus everolimus in advanced renal-cell carcinoma","volume":"373","author":"Motzer","year":"2015","journal-title":"N. Engl. J. Med."},{"issue":"14","key":"10.1016\/j.biopha.2023.115522_bib101","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1056\/NEJMoa1712126","article-title":"Nivolumab plus Ipilimumab versus sunitinib in advanced renal-cell carcinoma","volume":"378","author":"Motzer","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.biopha.2023.115522_bib102","article-title":"Cuproptosis-related gene FDX1 expression correlates with the prognosis and tumor immune microenvironment in clear cell renal cell carcinoma","volume":"13","author":"Wang","year":"2022","journal-title":"Front. Immunol."},{"issue":"10","key":"10.1016\/j.biopha.2023.115522_bib103","first-page":"13","article-title":"Song L. prognostic, clinicopathological, and function of key cuproptosis regulator FDX1 in clear cell renal cell carcinoma","author":"Zeng","year":"2022","journal-title":"Genes"},{"key":"10.1016\/j.biopha.2023.115522_bib104","article-title":"FDX1 expression predicts favourable prognosis in clear cell renal cell carcinoma identified by bioinformatics and tissue microarray analysis","volume":"13","author":"Huang","year":"2022","journal-title":"Front. Genet."},{"issue":"1","key":"10.1016\/j.biopha.2023.115522_bib105","doi-asserted-by":"crossref","DOI":"10.3390\/cells12010173","article-title":"Cuproptosis-Related MiR-21-5p\/FDX1 Axis in Clear Cell Renal Cell Carcinoma and Its Potential Impact on Tumor Microenvironment","volume":"12","author":"Xie","year":"2022","journal-title":"Cells"},{"issue":"13","key":"10.1016\/j.biopha.2023.115522_bib106","doi-asserted-by":"crossref","first-page":"6117","DOI":"10.18632\/aging.204807","article-title":"Confirmation of the predictive function of cuproptosis-related gene FDX1 in clear cell renal carcinoma using qRT-PCR and western blotting","volume":"15","author":"Cai","year":"2023","journal-title":"Aging"},{"issue":"5","key":"10.1016\/j.biopha.2023.115522_bib107","first-page":"13","article-title":"A novel cuproptosis-related prognostic gene signature and validation of differential expression in clear cell renal cell carcinoma","author":"Bian","year":"2022","journal-title":"Genes"},{"key":"10.1016\/j.biopha.2023.115522_bib108","doi-asserted-by":"crossref","first-page":"2124088","DOI":"10.1155\/2022\/2124088","article-title":"A novel cuproptosis-related prognostic model and the hub gene FDX1 predict the prognosis and correlate with immune infiltration in clear cell renal cell carcinoma","volume":"2022","author":"Zhang","year":"2022","journal-title":"J. Oncol."},{"key":"10.1016\/j.biopha.2023.115522_bib109","article-title":"Cuproptosis-related 4-gene risk model for predicting immunotherapy drug response and prognosis of kidney renal clear cell carcinoma","author":"Guo","year":"2023","journal-title":"Chin. Med. Sci. J. = Chung-kuo i hsueh K. 'o hsueh tsa chih"},{"key":"10.1016\/j.biopha.2023.115522_bib110","doi-asserted-by":"crossref","first-page":"1132661","DOI":"10.3389\/fimmu.2023.1132661","article-title":"Integrated single-cell and bulk characterization of cuproptosis key regulator PDHB and association with tumor microenvironment infiltration in clear cell renal cell carcinoma","volume":"14","author":"Wu","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.biopha.2023.115522_bib111","article-title":"Cuproptosis status affects treatment options about immunotherapy and targeted therapy for patients with kidney renal clear cell carcinoma","volume":"13","author":"Zhang","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.biopha.2023.115522_bib112","article-title":"Comprehensive investigation into cuproptosis in the characterization of clinical features, molecular characteristics, and immune situations of clear cell renal cell carcinoma","volume":"13","author":"Wang","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.biopha.2023.115522_bib113","doi-asserted-by":"crossref","first-page":"1071694","DOI":"10.3389\/fgene.2023.1071694","article-title":"Cuproptosis-related gene FDX1 as a prognostic biomarker for kidney renal clear cell carcinoma correlates with immune checkpoints and immune cell infiltration","volume":"14","author":"Yao","year":"2023","journal-title":"Front Genet"},{"issue":"11\u201312","key":"10.1016\/j.biopha.2023.115522_bib114","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1007\/s10495-022-01769-2","article-title":"Cuproptosis identifies respiratory subtype of renal cancer that confers favorable prognosis","volume":"27","author":"Li","year":"2022","journal-title":"Apoptosis: Int. J. Program. Cell Death"},{"issue":"8","key":"10.1016\/j.biopha.2023.115522_bib115","doi-asserted-by":"crossref","first-page":"3947","DOI":"10.62347\/ETJH6697","article-title":"The potential value of cuprotosis (copper-induced cell death) in the therapy of clear cell renal cell carcinoma","volume":"12","author":"Qi","year":"2022","journal-title":"Am. J. Cancer Res."},{"issue":"1","key":"10.1016\/j.biopha.2023.115522_bib116","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1186\/s40001-023-01221-4","article-title":"Multi-omics analysis uncovers clinical, immunological, and pharmacogenomic implications of cuproptosis in clear cell renal cell carcinoma","volume":"28","author":"Zhu","year":"2023","journal-title":"Eur. J. Med. Res."},{"issue":"1","key":"10.1016\/j.biopha.2023.115522_bib117","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1186\/s40001-023-01137-z","article-title":"Cuproptosis-related ferroptosis genes for predicting prognosis in kidney renal clear cell carcinoma","volume":"28","author":"Luo","year":"2023","journal-title":"Eur. J. Med. Res."},{"key":"10.1016\/j.biopha.2023.115522_bib118","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2022.983445","article-title":"Molecular subtypes based on cuproptosis regulators and immune infiltration in kidney renal clear cell carcinoma","volume":"13","author":"Liu","year":"2022","journal-title":"Front. Genet."},{"key":"10.1016\/j.biopha.2023.115522_bib119","first-page":"13","article-title":"Cuproptosis-related modification patterns depict the tumor microenvironment, precision immunotherapy, and prognosis of kidney renal clear cell carcinoma","author":"Cai","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.biopha.2023.115522_bib120","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.cancergen.2023.03.002","article-title":"Expression and potential immune involvement of cuproptosis in kidney renal clear cell carcinoma","volume":"274\u2013275","author":"Liu","year":"2023","journal-title":"Cancer Genet."},{"issue":"4","key":"10.1016\/j.biopha.2023.115522_bib121","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1038\/s41435-023-00211-0","article-title":"Integrated analyses reveal the prognostic, immunological features and mechanisms of cuproptosis critical mediator gene FDX1 in KIRC","volume":"24","author":"Wang","year":"2023","journal-title":"Genes Immun."},{"key":"10.1016\/j.biopha.2023.115522_bib122","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.919083","article-title":"Molecular subtyping based on cuproptosis-related genes and characterization of tumor microenvironment infiltration in kidney renal clear cell carcinoma","volume":"12","author":"Ji","year":"2022","journal-title":"Front Oncol."},{"key":"10.1016\/j.biopha.2023.115522_bib123","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.971142","article-title":"The cuproptosis-associated 13 gene signature as a robust predictor for outcome and response to immune- and targeted-therapies in clear cell renal cell carcinoma","volume":"13","author":"Yuan","year":"2022","journal-title":"Front Immunol."},{"issue":"6","key":"10.1016\/j.biopha.2023.115522_bib124","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1016\/j.humpath.2015.02.013","article-title":"Succinate dehydrogenase B: a new prognostic biomarker in clear cell renal cell carcinoma","volume":"46","author":"Cornejo","year":"2015","journal-title":"Hum. Pathol."},{"issue":"42","key":"10.1016\/j.biopha.2023.115522_bib125","doi-asserted-by":"crossref","first-page":"4709","DOI":"10.1038\/s41388-022-02460-1","article-title":"ISCA2 inhibition decreases HIF and induces ferroptosis in clear cell renal carcinoma","volume":"41","author":"Green","year":"2022","journal-title":"Oncogene"},{"issue":"4","key":"10.1016\/j.biopha.2023.115522_bib126","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1016\/j.bbrc.2015.03.130","article-title":"Metabolic signatures of renal cell carcinoma","volume":"460","author":"Lim","year":"2015","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"1","key":"10.1016\/j.biopha.2023.115522_bib127","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1186\/s12885-022-10278-z","article-title":"Exploration of the role of Cuproptosis genes and their related long non-coding RNA in clear cell renal cell carcinoma: a comprehensive bioinformatics study","volume":"22","author":"Xia","year":"2022","journal-title":"BMC Cancer"},{"key":"10.1016\/j.biopha.2023.115522_bib128","doi-asserted-by":"crossref","first-page":"4673514","DOI":"10.1155\/2022\/4673514","article-title":"A cuproptosis-related lncRNAs signature could accurately predict prognosis in patients with clear cell renal cell carcinoma","volume":"2022","author":"Zhang","year":"2022","journal-title":"Anal. Cell Pathol."},{"issue":"22","key":"10.1016\/j.biopha.2023.115522_bib129","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.21037\/atm-22-5204","article-title":"Clinical significance and immune landscape of cuproptosis-related lncRNAs in kidney renal clear cell carcinoma: a bioinformatical analysis","volume":"10","author":"Li","year":"2022","journal-title":"Ann. Transl. Med"},{"key":"10.1016\/j.biopha.2023.115522_bib130","doi-asserted-by":"crossref","first-page":"7219794","DOI":"10.1155\/2023\/7219794","article-title":"Construction and validation of a novel cuproptosis-related seven-lncRNA signature to predict the outcomes, immunotherapeutic responses, and targeted therapy in patients with clear cell renal cell carcinoma","volume":"2023","author":"Zhang","year":"2023","journal-title":"Dis. Markers"},{"key":"10.1016\/j.biopha.2023.115522_bib131","article-title":"Cuproptosis-associated lncRNA establishes new prognostic profile and predicts immunotherapy response in clear cell renal cell carcinoma","volume":"13","author":"Xu","year":"2022","journal-title":"Front Genet"},{"issue":"1","key":"10.1016\/j.biopha.2023.115522_bib132","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1186\/s12885-023-10639-2","article-title":"Bioinformatics analysis and experimental validation of cuproptosis-related lncRNA LINC02154 in clear cell renal cell carcinoma","volume":"23","author":"Shen","year":"2023","journal-title":"BMC Cancer"},{"issue":"6","key":"10.1016\/j.biopha.2023.115522_bib133","first-page":"2617","article-title":"Cuproptosis-related LINC01711 promotes the progression of kidney renal clear cell carcinoma","volume":"13","author":"Zhang","year":"2023","journal-title":"Am. J. Cancer Res."},{"key":"10.1016\/j.biopha.2023.115522_bib134","doi-asserted-by":"crossref","first-page":"1103986","DOI":"10.3389\/fphar.2022.1103986","article-title":"Cuproptosis-related lncRNA signatures predict prognosis and immune relevance of kidney renal papillary cell carcinoma","volume":"13","author":"Xie","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.biopha.2023.115522_bib135","doi-asserted-by":"crossref","first-page":"1009555","DOI":"10.3389\/fgene.2022.1009555","article-title":"Prognostic value and immunological characteristics of a novel cuproptosis-related long noncoding RNAs risk signature in kidney renal clear cell carcinoma","volume":"13","author":"Hong","year":"2022","journal-title":"Front Genet"},{"key":"10.1016\/j.biopha.2023.115522_bib136","first-page":"9","article-title":"A cuproptosis-related lncRNA signature identified prognosis and tumour immune microenvironment in kidney renal clear cell carcinoma","author":"Xin","year":"2022","journal-title":"Front. Mol. Biosci."},{"key":"10.1016\/j.biopha.2023.115522_bib137","doi-asserted-by":"crossref","first-page":"12","DOI":"10.3390\/biom12121890","article-title":"Identification and validation of cuproptosis-related LncRNA signatures in the prognosis and immunotherapy of clear cell renal cell carcinoma using machine learning","volume":"12","author":"Bai","year":"2022","journal-title":"Biomolecules"}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332223013203?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332223013203?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T00:44:16Z","timestamp":1778633056000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332223013203"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":137,"alternative-id":["S0753332223013203"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2023.115522","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The potential of targeting cuproptosis in the treatment of kidney renal clear cell carcinoma","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2023.115522","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"115522"}}